.png)
IMH Publication
Mapping the PHQ8 to EQ5D, HUI3 and SF6D in patients with Depression
13 September 2021
This study maps the PHQ-8 depression scale to three health utility tools, supporting cost-effectiveness analyses of depression treatments in Asian patients.
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
Edimansyah Abdin, Siow Ann Chong, Esmond Seow, Kelvin Bryan Tan & Mythily Subramaniam
Background
There is limited evidence of mapping clinical instruments to a generic preference-based instrument in Asian patient populations. The current study aims to map the eight-item Patient Health Questionnaire depression scale (PHQ-8) onto the EuroQol Five-Dimension (EQ-5D), the Health Utilities Index Mark 3 (HUI3) and the Short Form Six-Dimension (SF-6D) which helps to inform future cost-utility analyses of treatments for depression.
Methods
A total of 249 participants who had completed PHQ-8, EQ-5D, SF-6D and HUI3 questionnaires were included in the analyses. A beta regression mixture model was used to map the utility scores as a function of PHQ-8 total scores, PHQ-squared, age and gender. The predictive accuracy of the models was examined using mean absolute error and root mean square error.
Results
The results were compared against two common regression methods including Ordinary Least Square (OLS) and Tobit regression models. The mean age of the sample was 36.2 years (SD = 11.1). The mean EQ-5D-3L, EQ-5D-5L, HUI3 and SF-6D utility scores were 0.615, 0.709, 0.461 and 0.607, respectively. The EQ-5D-3L, EQ-5D-5L and SF-6D utility scores were best predicted by the beta mixture regression model consisting of PHQ-8 total sores, PHQ-squared, and covariates including age and gender. The HUI3 was best predicted by the OLS regression model.
Conclusions
The current study provides important evidence to clinicians and researchers about the mapping algorithms that can be used in economic evaluation among patients with depression.